Osiris announces scientific manuscript reporting human CVAM inhibits bacteria growth
Osiris Therapeutics announced a new peer-reviewed manuscript "Human cryopreserved viable amniotic membrane inhibits the growth of bacteria associated with chronic wounds" (Mao et al.) has been published in the Journal of Diabetic Foot Complications. January 13, 2017